RedHill Biopharma (RDHL) Asset Utilization Ratio (2016 - 2024)
Historic Asset Utilization Ratio for RedHill Biopharma (RDHL) over the last 12 years, with Q4 2024 value amounting to 0.09.
- RedHill Biopharma's Asset Utilization Ratio fell 8568.89% to 0.09 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.09, marking a year-over-year decrease of 8568.89%. This contributed to the annual value of 391482.11 for FY2024, which is 54530810404.32% up from last year.
- RedHill Biopharma's Asset Utilization Ratio amounted to 0.09 in Q4 2024, which was down 8568.89% from 0.24 recorded in Q2 2024.
- RedHill Biopharma's Asset Utilization Ratio's 5-year high stood at 0.76 during Q2 2023, with a 5-year trough of 0.05 in Q1 2020.
- Moreover, its 5-year median value for Asset Utilization Ratio was 0.42 (2021), whereas its average is 0.38.
- As far as peak fluctuations go, RedHill Biopharma's Asset Utilization Ratio soared by 71254.45% in 2021, and later tumbled by 8568.89% in 2024.
- RedHill Biopharma's Asset Utilization Ratio (Quarter) stood at 0.37 in 2020, then rose by 26.61% to 0.47 in 2021, then dropped by 16.2% to 0.39 in 2022, then surged by 60.19% to 0.63 in 2023, then plummeted by 85.69% to 0.09 in 2024.
- Its last three reported values are 0.09 in Q4 2024, 0.24 for Q2 2024, and 0.63 during Q4 2023.